» Articles » PMID: 30283712

Perception of Pulmonary Function in Children with Asthma and Cystic Fibrosis

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Under-perception of pulmonary dysfunction may delay appropriate treatment, while over-perception may result in unnecessary treatments. To evaluate the ability of patients with asthma or cystic fibrosis and their subspecialty caregivers to assess changes in lung function based on their subjective clinical impressions. Patients were asked to qualitatively describe how they felt compared to their prior visit (same/better/worse) and to quantitatively estimate their forced expiratory volume in 1 s (FEV) after being reminded of their FEV at the prior visit. Providers made similar estimates based on history and physical examination and knowledge of prior FEV. After adjusting for relevant clinical covariates, lung function estimates were categorized as accurate (±5% of measured FEV), overestimated (>5% above measured), and underestimated (>5% below measured). One hundred nine patients estimated FEV on 179 occasions. Concordance between patient qualitative assessment and FEV-based categories was low ( = 0.08); 44% of patients reported feeling better than the FEV-based category showed. Quantitatively, 56% of patient estimates were accurate, 18% were underestimated, and 26% overestimated; accuracy improved with age (odds ratio = 1.16,  = 0.01). Concordance between provider qualitative assessments and FEV-based category was moderate ( = 0.35); about 19% said their patient looked better than the FEV-based category showed. Quantitatively, 65% of provider estimates were accurate, 16% were underestimated, and 19% were overestimated; accuracy improved with years of experience. Patients' and providers' perceptions of lung function were low to moderately accurate. Relying on subjective impression may place patients at risk for unnecessary treatments or increased morbidity. These findings highlight the importance of objective lung function assessment.

Citing Articles

Technical validity and usability of a novel smartphone-connected spirometry device for pediatric patients with asthma and cystic fibrosis.

Kruizinga M, Essers E, Stuurman F, Zhuparris A, van Eik N, Janssens H Pediatr Pulmonol. 2020; 55(9):2463-2470.

PMID: 32592537 PMC: 7496177. DOI: 10.1002/ppul.24932.

References
1.
Lechtzin N, West N, Allgood S, Wilhelm E, Khan U, Mayer-Hamblett N . Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial. Contemp Clin Trials. 2013; 36(2):460-9. PMC: 3844027. DOI: 10.1016/j.cct.2013.09.004. View

2.
Ziegler B, Fernandes A, Sanches P, Silva Junior D, Thome P, Dalcin P . Dyspnea perception in cystic fibrosis patients. Braz J Med Biol Res. 2013; 46(10):897-903. PMC: 3854316. DOI: 10.1590/1414-431X20133139. View

3.
Feldman J, Steinberg D, Kutner H, Eisenberg N, Hottinger K, Sidora-Arcoleo K . Perception of pulmonary function and asthma control: the differential role of child versus caregiver anxiety and depression. J Pediatr Psychol. 2013; 38(10):1091-100. PMC: 3809726. DOI: 10.1093/jpepsy/jst052. View

4.
Abbott J, Dodd M, Webb A . Different perceptions of disease severity and self care between patients with cystic fibrosis, their close companions, and physician. Thorax. 1995; 50(7):794-6. PMC: 474657. DOI: 10.1136/thx.50.7.794. View

5.
Miller M . Potential problems in peak expiratory flow data used to diagnose occupational asthma. Occup Med (Lond). 1996; 46(3):239-41. DOI: 10.1093/occmed/46.3.239. View